Abstract
Over the last 10 years, there have been considerable changes in how we manage Barrett’s neoplasia, with the shift away from conventional surgery and moving toward endotherapy for treating dysplasia and early cancer. In this editorial, we will review these changes and look forward to the possible developments which may occur over the next decade.
| Original language | English |
|---|---|
| Pages (from-to) | 543-545 |
| Journal | Expert Review of Gastroenterology & Hepatology |
| Volume | 9 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - May 2015 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Advanced endoscopic therapeutics in Barrett’s neoplasia: where are we now and where are we heading?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver